FIELD: medicine.
SUBSTANCE: invention relates to medicine, namely to clinical diagnostics. Risk factors are determined: the presence of vaccination, self-treatment before hospitalization with antiviral drugs: Favipiravir, Triazaverine or Coronavir, the presence of muscle pain, shortness of breath, difficulty nasal breathing, dyspeptic disorders before hospitalization, a history of: Parkinson's disease, rheumatoid arthritis, diabetes mellitus, chronic heart failure, chronic venous insufficiency, hypertension or arterial hypertension, myocardial infarction or acute cerebrovascular accident in the anamnesis, coronary heart disease, iron deficiency anemia, chronic kidney disease, cancer, intestinal cancer, kidney disease, duodenal ulcer. Determine body temperature, respiratory rate and age group. According to the point system, each indicator is evaluated. Then the probability coefficient of predicting the result is calculated according to the original formula. If the CPR value is greater than 0.53, a high probability of death is predicted.
EFFECT: method makes it possible to predict the probability of death in patients aged 60 years and older with COVID-19 hospitalized in a hospital, allows you to choose the optimal personalized approach to the treatment of COVID-19 patients, which will avoid the development of situations that significantly increase the frequency of complications, adverse outcomes and large material costs.
1 cl, 1 dwg, 2 tbl, 2 ex
Title | Year | Author | Number |
---|---|---|---|
METHOD FOR PREDICTING PROBABILITY OF DEATH IN PATIENTS WITH COVID-19 HOSPITALIZED ON BASIS OF LABORATORY AND INSTRUMENTAL STUDIES | 2023 |
|
RU2806726C1 |
METHOD FOR PREDICTING THE RISK OF DEATH WITHIN 6 MONTHS AFTER SUFFERING A NEW CORONAVIRUS INFECTION COVID-19 | 2021 |
|
RU2766302C1 |
METHOD OF PREDICTING RISK OF IN-HOSPITAL MORTALITY IN PATIENTS WITH COVID-19 | 2023 |
|
RU2805928C1 |
METHOD OF PREDICTING THE RISK OF DEATH FROM COVID-19 IN YOUNG PATIENTS | 2023 |
|
RU2803002C1 |
METHOD FOR PREDICTING RISK OF DEATH AT HOSPITAL STAGE IN PATIENTS WITHOUT ST-SEGMENT ELEVATION MYOCARDIAL INFARCTION WHO HAVE UNDERGONE NEW COVID-19 CORONAVIRUS INFECTION, TAKING INTO ACCOUNT THEIR IMMUNOLOGICAL STATUS | 2022 |
|
RU2781565C1 |
METHOD FOR PREDICTION OF LETHAL OUTCOME IN PATIENTS WITH CYTOKINE STORM ASSOCIATED WITH COVID-19 | 2022 |
|
RU2825710C2 |
METHOD OF PREDICTING THE RISK OF DEATH IN PATIENTS WITH COVID-19 | 2023 |
|
RU2812749C1 |
METHOD OF PREDICTING DEVELOPMENT OF THROMBOEMBOLIC COMPLICATIONS IN PATIENTS WITH COVID-19 | 2023 |
|
RU2812718C1 |
METHOD FOR PREDICTING THE LETHAL OUTCOME IN PATIENTS WITH SEVERE CoVID-19 | 2021 |
|
RU2780748C1 |
METHOD FOR PREDICTION OF URGENT CARDIOVASCULAR COMPLICATIONS IN ACUTE CORONARY SYNDROME IN PATIENTS WITH ONCOLOGICAL DISEASE IN PAST HISTORY | 2020 |
|
RU2741195C1 |
Authors
Dates
2023-10-13—Published
2023-07-25—Filed